BERKLEY CARE 3 LIMITED

Company Registration Number:
06032284 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2022

Period of accounts

Start date: 01 October 2021

End date: 31 December 2022

BERKLEY CARE 3 LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Balance sheet
Notes

BERKLEY CARE 3 LIMITED

Balance sheet

As at 31 December 2022


Notes

15 months to 31 December 2022

2021


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 12,863,848 13,130,000
Investments: 4 0 100
Total fixed assets: 12,863,848 13,130,100
Current assets
Stocks: 0 0
Debtors: 5 2,905,713 2,042,784
Cash at bank and in hand: 110,035 73,004
Investments:   0 0
Total current assets: 3,015,748 2,115,788
Creditors: amounts falling due within one year: 6 (1,293,871) (1,223,543)
Net current assets (liabilities): 1,721,877 892,245
Total assets less current liabilities: 14,585,725 14,022,345
Creditors: amounts falling due after more than one year: 7 0 (11,523,075)
Provision for liabilities: 0 (69,051)
Total net assets (liabilities): 14,585,725 2,430,219
Capital and reserves
Called up share capital: 1 1
Share premium account: 0 0
Revaluation reserve:86,350,6726,350,672
Other reserves: 0 0
Profit and loss account: 8,235,052 (3,920,454)
Shareholders funds: 14,585,725 2,430,219

The notes form part of these financial statements

BERKLEY CARE 3 LIMITED

Balance sheet statements

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 August 2024
and signed on behalf of the board by:

Name: Peter Stuart Cameron
Status: Director

The notes form part of these financial statements

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

2. Employees

15 months to 31 December 2022 2021
Average number of employees during the period 0 0

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

3. Tangible Assets

Total
Cost £
At 01 October 2021 14,243,746
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 December 2022 14,243,746
Depreciation
At 01 October 2021 1,113,746
Charge for year 266,152
On disposals 0
Other adjustments 0
At 31 December 2022 1,379,898
Net book value
At 31 December 2022 12,863,848
At 30 September 2021 13,130,000

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

4. Fixed investments

6. Fixed asset investments Investments in subsidiary companies £ At 1 October 2021 100 Disposals (100) At 31 December 2022 On 10 November 2022 the Company sold 100% of the share capital in Berkley Care Blenheim Limited, to Korian UK Limited as part of a group restructure.

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

5. Debtors

15 months to 31 December 2022 2021
££
Debtors due after more than one year: 0 0

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

6. Creditors: amounts falling due within one year note

8. Creditors: Amounts falling due within one year 31 30 December September 2022 2021 £ £ Bank loans 539,592 Amounts owed to group undertakings 1,270,524 680,589 Corporation tax 17,347 Accruals and deferred income 6,000 3,362 1,293,871 1,223,543 Amounts due to group undertakings incur no interest and are repayable on demand.

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

7. Creditors: amounts falling due after more than one year note

31 30 December September 2022 2021 £ £ Bank loans 10,127,075 Other creditors 1,396,000 11,523,075

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

8. Revaluation reserve

15 months to 31 December 2022
£
Balance at 01 October 2021 6,350,672
Surplus or deficit after revaluation 0
Balance at 31 December 2022 6,350,672

BERKLEY CARE 3 LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

9. Post balance sheet events

On 10 April 2024, Clariane SE sold its assets in the United Kingdom to Elevation Healthcare Property, a UK investment fund specialising in healthcare real estate, managed by Elevation Advisors LLP.